Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein.
about
MiR-122 in hepatitis B virus and hepatitis C virus dual infectionHepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection.Regulation of Hepatitis B Virus Replication by the Phosphatidylinositol 3-Kinase-Akt Signal Transduction PathwayMolecular mechanisms underlying occult hepatitis B virus infection.Update on occult hepatitis B virus infectionMembrane binding properties and terminal residues of the mature hepatitis C virus capsid protein in insect cells.Occult HBV infection: a faceless enemy in liver cancer development.Association of hepatitis status with surgical outcomes in patients with dual hepatitis B and C related hepatocellular carcinomaInsulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progressionHepatitis B virus and hepatitis C virus dual infection.Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.Detection of hepatitis B and C viruses in almost all hepatocytes by modified PCR-based in situ hybridization.Current Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in Harmony.Influence of occult hepatitis B virus infection in chronic hepatitis C outcomesReactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use.Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant womenHepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.Dual chronic hepatitis B virus and hepatitis C virus infection.Management of patients co-infected with HBV and HCV.Occult hepatitis B infection and its possible impact on chronic hepatitis C virus infection.The role of anti-core antibody response in the detection of occult hepatitis B virus infection.Multiple infections and cancer: implications in epidemiology.Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review.Molecular mechanisms underlying HBsAg negativity in occult HBV infection.Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously.Interference of replication between hepatitis B and C viruses in patients infected with HIV.HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals.Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein.Clinical analysis of patients suffering from chronic hepatitis B superinfected with other hepadnaviruses.Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.Occult hepatitis B in blood donors: a description of two cases.Prevalence, incidence, and clinical relevance of the reverse transcriptase V207I mutation outside the YMDD motif of the hepatitis B virus polymerase during lamivudine therapy.Expression of Hepatitis B Virus Surface Antigen Containing Y100C Variant Frequently Detected in Occult HBV InfectionThe spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management.A zebrafish model of intrahepatic cholangiocarcinoma by dual expression of hepatitis B virus X and hepatitis C virus core protein in liver.Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus.
P2860
Q27008894-BCCF6953-3961-426E-9DE9-71527D013503Q27472769-058FDD88-A5A1-4AE0-8A87-54E690A96100Q27481454-5580AC61-7370-4DFC-9136-8F0C44D646F4Q27686923-2955C228-F176-4E3F-8225-148405781FB5Q28070317-E2E4D356-137B-44C4-9349-7FB4226AC18BQ31120481-8D0C8CBB-F2F7-42A3-8365-C217F52D24A2Q33584773-624351C8-F7A1-4B6B-B6AB-5371576C0342Q33730678-E2A1D322-E908-487A-817A-3CA1748B5DE2Q34263370-AC9EC3C7-AD80-41C0-906B-4C2A3FE5D51CQ34404975-C7FF3646-CD3A-4EA8-B354-D2A2A46B76E6Q34425267-BF678678-1840-4820-AC2F-545BD88E2288Q34489553-91A8E593-72CA-4526-B62B-CE788778F2EBQ34502980-B7EBA962-8422-4EA6-8DEE-EA56CD082E67Q34757394-78630404-F6CD-41C8-B43B-1BD446F5C9FBQ36294422-2FFE169E-C124-4578-B3CB-779E25BCDBFFQ36575228-7A9CE59D-8F7A-4785-B3BB-AAE3EF47EFC0Q36999993-317EEF79-6536-4BCA-A01F-8A5D89E15D05Q37132382-B3D0484F-2A0F-40B9-8BA4-EC6BF2DC4465Q37207070-5FDBDEC2-C757-4E20-A86B-E9911547004BQ37466211-4B3B3D50-5F0D-4761-B015-A0E61F9684ABQ37503341-B98D446E-B3CC-46F9-AFF8-E78B6ED92AE0Q37606222-EB81A9D3-0505-4CBA-A221-B875D9C8C179Q37634106-92545E44-E1EF-4E75-A8F4-D07F101B0251Q38126931-E67B9714-AD85-4B89-9155-6C09DFC8BB08Q38179533-0CE20C6D-6079-4024-B03D-0826AC5006B8Q38536404-0499E612-51BF-437B-9DF2-15A29CD9F303Q38805093-185164CE-F26A-4FEA-872D-D4084B77F26DQ39080534-B4C0D8E3-4F44-482C-A646-9044046D1416Q39543611-4C77E7B0-A72A-4269-9095-DE600621133CQ40124392-9C603AAF-2169-4762-940E-DB319DE2D358Q40589165-A6ED47D8-6A9A-4EBD-BC10-C006838E1225Q40934262-47268202-3133-4BF7-BC3C-9616E5E5790EQ41524630-98AFB592-525D-49D7-8CEF-0F5BD9EC1F67Q41774248-666484E8-4756-4330-8EAA-5A7E7DE4D34EQ41844014-35B2FB42-6957-498A-A3C2-51AB28D0BD4FQ42600607-0C446C08-F656-4DC5-8FFC-514E75CDAE7AQ42746527-843D5461-8967-4384-9055-957520F531D3Q42981671-25BC9A56-36C7-4D90-B8BF-A563B284E605Q43030555-FAC422E0-7C7E-4B35-82C3-C73EFB4F127CQ43037993-CE3CDF90-68B5-414E-970F-2C38664DCABB
P2860
Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Mechanisms for inhibition of h ...... epatitis C virus core protein.
@en
Mechanisms for inhibition of h ...... epatitis C virus core protein.
@nl
type
label
Mechanisms for inhibition of h ...... epatitis C virus core protein.
@en
Mechanisms for inhibition of h ...... epatitis C virus core protein.
@nl
prefLabel
Mechanisms for inhibition of h ...... epatitis C virus core protein.
@en
Mechanisms for inhibition of h ...... epatitis C virus core protein.
@nl
P2093
P2860
P356
P1476
Mechanisms for inhibition of h ...... hepatitis C virus core protein
@en
P2093
Chih-Fei Kao
Chun-Ming Chen
Chwen-Ming Shih
Ming-Jen Hsu
Shao-Hung Wang
Shiow-Yi Chen
Yan-Hwa Wu Lee
P2860
P304
P356
10.1074/JBC.M204241200
P407
P577
2002-10-24T00:00:00Z